Web Sify
Follow us on
Mail
Print

Dr Reddy's launches prostate cancer drug in India

Source : REUTERS
Last Updated: Sat, Dec 08, 2012 18:41 hrs

MUMBAI, Dec 7 (Reuters) - Dr. Reddy's Laboratories Ltd , India's No. 2 drugmaker by sales, said it has launched Pamorelin, a drug to treat prostate cancer, in India.

Dr Reddy's will import and sell Pamorelin in India through an exclusive marketing deal with Switzerland-based Debiopharm Group, the Indian company said in a statement on Friday. (Reporting by Kaustubh Kulkarni; Editing by Prateek Chatterjee)


More from Sify:
blog comments powered by Disqus
  Cities   Price (10g)
  Chennai   Rs. 24500.00 (-0.33%)
  Mumbai   Rs. 25480.00 (-0.08%)
  Delhi   Rs. 25200.00 (0%)
  Kolkata   Rs. 25000.00 (0%)
  Kerala   Rs. 24400.00 (-0.41%)
  Bangalore   Rs. 24450.00 (0%)
  Hyderabad   Rs. 24580.00 (0%)
talking point on sify finance